Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · IEX Real-Time Price · USD
1.720
-0.030 (-1.71%)
At close: Mar 28, 2024, 4:00 PM
1.750
+0.030 (1.74%)
After-hours: Mar 28, 2024, 7:58 PM EDT

Spero Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018201720162015
Revenue
103.7853.5118.269.3318.153.971.980.340
Revenue Growth (YoY)
93.95%193.10%95.67%-48.59%357.56%100.40%490.75%--
Gross Profit
103.7853.5118.269.3318.153.971.980.340
Selling, General & Admin
25.5536.4841.721.4415.5912.8910.847.222.2
Research & Development
51.4447.5964.536765.7833.8932.8726.3311.13
Other Operating Expenses
5.3111.630000000
Operating Expenses
82.395.71106.2388.4481.3646.7743.7133.5613.33
Operating Income
21.48-42.2-87.97-79.11-63.22-42.81-41.73-33.22-13.33
Interest Expense / Income
02.611.94000000
Other Expense / Income
-3.921.61-0.16-0.83-2.29-1.14-2.99-7.73-0.17
Pretax Income
25.4-46.42-89.76-78.28-60.93-41.66-38.74-25.49-13.15
Income Tax
2.600000000
Net Income
22.81-46.42-89.76-78.28-60.93-41.66-38.74-25.49-13.15
Preferred Dividends
0000007.354.443.27
Net Income Common
22.81-46.42-89.76-78.28-60.93-41.66-46.1-29.93-13.43
Shares Outstanding (Basic)
533831221816300
Shares Outstanding (Diluted)
533831221816300
Shares Change
40.98%21.65%38.01%23.27%13.49%518.58%728.67%23.48%-
EPS (Basic)
0.43-1.23-2.91-3.52-3.35-2.60-17.82-95.87-53.11
EPS (Diluted)
0.43-1.23-2.91-3.52-3.35-2.60-17.82-95.87-53.11
Free Cash Flow
-33-7.73-64.35-85.87-50.33-42.06-39.14-29.79-9.84
Free Cash Flow Per Share
-0.63-0.21-2.08-3.84-2.77-2.63-15.13-95.43-38.92
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%-
Operating Margin
20.70%-78.86%-481.87%-847.94%-348.36%-1079.32%-2108.64%-9916.72%-
Profit Margin
21.98%-86.74%-491.65%-839.01%-335.73%-1050.48%-2329.31%-8933.73%-
Free Cash Flow Margin
-31.79%-14.45%-352.47%-920.39%-277.37%-1060.54%-1977.67%-8892.24%-
Effective Tax Rate
10.23%--------
EBITDA
25.77-42.94-87.17-77.52-60.18-41.25-38.38-25.21-13.14
EBITDA Margin
24.83%-80.25%-477.49%-830.86%-331.60%-1040.17%-1939.36%-7525.97%-
Depreciation & Amortization
0.370.870.650.760.750.410.360.280.01
EBIT
25.4-43.81-87.82-78.28-60.93-41.66-38.74-25.49-13.15
EBIT Margin
24.48%-81.87%-481.03%-839.01%-335.73%-1050.48%-1957.71%-7609.25%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).